← Back to All Stocks
ALX Oncology Holdings Inc. (ALXO) Analysis
Generated on: 2025-07-14 03:49:01 UTC
All stock prices are delayed.
Use of this site does not constitute financial advice.
Analysis Values
Current Price
$0.50
Predicted Price
$0.56
Expected Return
9.79%
Confidence Score
0.88
RSI (14)
49.78
MACD
-0.01
Volume
276,500
Float Shares
31,342,780
Reddit Posts
0
News Items
1
SEC Filings
0
Data Points
249
ALXO
ALX Oncology Holdings Inc.
9.79%
Price: $0.50
Confidence: 0.88
News
Low Float
Last updated: 2025-07-14 03:49:01
Technical Analysis
RSI: 49.78
MACD: -0.01
Risk Analysis
Volatility
105.65%
Max Drawdown
-95.01%
Beta
1.0
Risk Score
100
Social Sentiment
0
Social Sentiment Score (0-100)
Recent News
ALX Oncology’s CD47-blocker and Keytruda combo fails in two Phase II trials
Clinical Trials Arena - 2025-04-28 11:51
Despite the failures, ALX Oncology remains hopeful about evorpacept and is focusing on combination trials with other anti-cancer antibodies.
Reddit Discussions
No recent Reddit discussions found.
Recent SEC Filings
No recent SEC filings found.
